Publication:
IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

GÜLER, Beril

Mirapoglu, S.

Turkmen, A. Vehaboglu

Aki, H.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Keywords

Citation

ÇAKIR F. B. , GÜLER B., Cay A., Mirapoglu S., Turkmen A. V. , Aki H., -IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma-, PEDIATRIC BLOOD & CANCER, cilt.65, 2018

Endorsement

Review

Supplemented By

Referenced By

4

Views

0

Downloads


Sustainable Development Goals